Quality assessment of clinical trials in bladder cancer

Levels of sex hormones have limited effect on cognition in older men with or without prostate cancer.

Critical reviews in oncology/hematology·2009

Phase II study of troxacitabine (BCH-4556) in patients with advanced and/or metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada-Clinical Trials Group.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2003

A National Cancer Institute of Canada clinical trials group phase II study of eniluracil (776C85) and oral 5-fluorouracil in patients with advanced squamous cell head and neck cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2001

Family reports of cancer pain, pain relief, and prescription access.

Cancer practice·1999

Tuberculosis screening in private physicians' offices, Pennsylvania, 1996.

American journal of preventive medicine·1999

Mobilization of peripheral blood stem cells with docetaxel and cyclophosphamide (CY) in patients with metastatic breast cancer: a randomized trial of 3 vs 4 g/m2 of CY.

Bone marrow transplantation·1999

Challenges of Using Circulating Tumour DNA: Insights from Advanced Prostate Cancer.

European urology·2026

Impact of Treatment Intensification with Abiraterone on Fracture-related Hospitalisation in Newly Diagnosed Prostate Cancer: A Secondary Analysis of Two Randomised Phase 3 Trials Within the STAMPEDE Trial Platform.

European urology·2026

Why Look Further When the Solution Is in Front of You - or Is It? The Value of Confirmatory PSA in Prostate Cancer Screening.

European urology·2026

Darolutamide Plus Androgen-deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase 3 ARANOTE Trial.

European urology·2026

Oncostatin M as a Multifunctional Regulator of Breast Cancer Progression: Current Insights and Future Therapeutic Avenues.

IUBMB life·2026

Lymphatic vascular aging and age-related bone loss: current status and future perspectives.

Frontiers in immunology·2026

Microbiota-driven metabolic-immune crosstalk in breast cancer.

Frontiers in pharmacology·2026

The Coupled Physico-Biochemical Mechanisms of Skin Aging: From Dermal Fluid Dynamics and Mechanotransduction to Nutrient-Sensing Dysfunction.

Cureus·2026

The neuro-immune axis in cancer: mechanisms of neural regulation of immunity within the tumor microenvironment to promote cancer progression.

Frontiers in immunology·2026

Corrigendum to "Nanochelate-based BCc1 delivery and its impact on key regulatory pathways in BALB/c breast cancer: An analysis of Beclin-1, ATG-4B, ATG-7, and mTOR expression" [Biochem. Biophys. Rep. 45 (2026) 102418].

Biochemistry and biophysics reports·2026

Related Experiment Videos

Quality assessment of clinical trials in bladder cancer

Related Concept Videos

Levels of sex hormones have limited effect on cognition in older men with or without prostate cancer.

Phase II study of troxacitabine (BCH-4556) in patients with advanced and/or metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada-Clinical Trials Group.

A National Cancer Institute of Canada clinical trials group phase II study of eniluracil (776C85) and oral 5-fluorouracil in patients with advanced squamous cell head and neck cancer.

Family reports of cancer pain, pain relief, and prescription access.

Tuberculosis screening in private physicians' offices, Pennsylvania, 1996.

Mobilization of peripheral blood stem cells with docetaxel and cyclophosphamide (CY) in patients with metastatic breast cancer: a randomized trial of 3 vs 4 g/m2 of CY.

Challenges of Using Circulating Tumour DNA: Insights from Advanced Prostate Cancer.

Impact of Treatment Intensification with Abiraterone on Fracture-related Hospitalisation in Newly Diagnosed Prostate Cancer: A Secondary Analysis of Two Randomised Phase 3 Trials Within the STAMPEDE Trial Platform.

Why Look Further When the Solution Is in Front of You - or Is It? The Value of Confirmatory PSA in Prostate Cancer Screening.

Darolutamide Plus Androgen-deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase 3 ARANOTE Trial.

Oncostatin M as a Multifunctional Regulator of Breast Cancer Progression: Current Insights and Future Therapeutic Avenues.

Lymphatic vascular aging and age-related bone loss: current status and future perspectives.

Microbiota-driven metabolic-immune crosstalk in breast cancer.

The Coupled Physico-Biochemical Mechanisms of Skin Aging: From Dermal Fluid Dynamics and Mechanotransduction to Nutrient-Sensing Dysfunction.

The neuro-immune axis in cancer: mechanisms of neural regulation of immunity within the tumor microenvironment to promote cancer progression.

Corrigendum to "Nanochelate-based BCc1 delivery and its impact on key regulatory pathways in BALB/c breast cancer: An analysis of Beclin-1, ATG-4B, ATG-7, and mTOR expression" [Biochem. Biophys. Rep. 45 (2026) 102418].

Related Experiment Videos

Quality assessment of clinical trials in bladder cancer

Related Concept Videos

Related Articles